Cetera Investment Advisers
ARKG icon

Cetera Investment Advisers’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cetera Investment Advisers’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,500
Closed -$15K – 1772
2021
Q1 		$15K Buy
+1,500
New +$149K ﹤0.01% 1589

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Cetera Investment Advisers's ARKG Position: Q1 2026 in Review

Cetera Investment Advisers reduced its ARK Genomic Revolution ETF (ARKG) stake by 1.9% in Q1 2026, selling an estimated $59.2K and leaving 101,872 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2001.

Cetera Investment Advisers first reported a position in ARKG in Q3 2020 and has held it in 23 quarters since. The position peaked at $8.44M in Q1 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Cetera Investment Advisers held 101,872 shares of ARK Genomic Revolution ETF worth $2.69M as of Q1 2026.
  • Cetera Investment Advisers sold 2,023 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $59.2K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #2001 holding.
  • Cetera Investment Advisers first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 23 quarters since.
  • Cetera Investment Advisers's ARK Genomic Revolution ETF position peaked at $8.44M in Q1 2021.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.